Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

WELLCOVORIN

LEUCOVORIN CALCIUM

Standard Dose
EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview WELLCOVORIN is listed in Drugs@FDA under application 018342 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2026-03-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview WELLCOVORIN is listed in Drugs@FDA under application 018342 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2026-03-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.